To reduce the risk of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) CHADS2 score of at least 2 and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) in adults, following 5 to 10 days of initial therapy with a parenteral anticoagulant.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
